I am writing as a private specialist who wishes to remain completely anonymous due to concerns about potential repercussions from insurers and hospital management.
I would like to share my experience and several broader concerns regarding insurance clawbacks of professional fees. I believe this is an issue that deserves greater scrutiny, because it may affect not only doctors financially, but also clinical decision-making and patient access to care.
In my experience, one of the most concerning aspects is the pressure faced by specialists when they question a clawback. Doctors may be informed that their cases will be placed under review, and there can be an implicit concern that continued disagreement or non-compliance could affect their status as a panel specialist.
Even where no explicit threat is made, the imbalance in bargaining power can make individual specialists reluctant to challenge deductions.
Another major concern is retrospective clawback after prior approval. There are situations where treatment or procedures were performed only after obtaining the insurer’s prior approval or guarantee of payment.
The procedure is subsequently completed in good faith, yet months later the specialist is asked to refund part or all of the professional fee. This raises an important question: if an insurer has reviewed and approved treatment before it is performed, under what circumstances can that approval subsequently be used as a basis for recovery?
I am also concerned about the retrospective application of Ministry of Health (MOH) circulars, letters, policies, or interpretations. Where a circular or clarification was issued after a procedure has already been performed, applying that subsequent position retrospectively may create significant uncertainty for doctors who acted according to the information and requirements available to them at the time.
There is also a lack of an effective and transparent avenue for individual private specialists to seek clarification or redress. Doctors may approach hospitals, insurers or relevant authorities, but responses can be delayed or absent.
This leaves individual specialists in a particularly vulnerable position when dealing with large insurance organisations.
Hospital management can also be placed in a difficult position. Hospitals understandably wish to maintain their relationships with insurers and avoid losing panel arrangements.
However, this can result in specialists feeling pressured to accept clawbacks even when they have legitimate grounds to question them. The specialist is then effectively placed between defending their professional income and protecting the hospital’s commercial relationship with the insurer.
Another concern is the absence of what I would consider basic procedural safeguards in some clawback processes. Doctors may receive a clawback notice without a detailed explanation of the clinical basis for the deduction, the supporting evidence, or an opportunity to respond before recovery is made.
There should arguably be a clear process requiring reasons, evidence, an opportunity for the doctor to provide a response, and an independent avenue of appeal before professional fees are recovered.
Ultimately, I am concerned about the impact on patient care. If specialists become worried that clinically appropriate procedures may later result in financial clawbacks, there is a risk that doctors may become more cautious about offering certain procedures or may avoid taking on cases where the financial uncertainty is significant. This should not become a factor influencing clinical decisions.
I believe there is a need for greater regulatory oversight and clearer national guidance on insurance clawbacks. Such a framework could potentially address issues including:
- Whether and when a previously approved procedure can be subjected to retrospective recovery.
- Reasonable limitation periods for clawback claims.
- The circumstances in which an insurer may reopen an approved claim.
- Prohibition or safeguards against retrospective application of subsequently issued policies or circulars.
- Disclosure of the clinical and contractual basis for a clawback.
- A formal opportunity for specialists to respond before deductions are made.
- Independent dispute resolution or appeal mechanisms.
- Protection against retaliatory action, including removal from a panel solely because a doctor has legitimately challenged a clawback.
I am not suggesting that insurers should be prevented from identifying genuine overbilling, fraud, or inappropriate claims. There must obviously be mechanisms to protect the integrity of the health care financing system.
However, there should also be a fair and transparent process that protects doctors who have acted in good faith, particularly where treatment was previously authorised.
The author is a specialist doctor in the private sector. CodeBlue is providing the author anonymity because they fear repercussions from their hospital or insurer.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
